Halogenizing stress and its biomarkers

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk

Volumn , Issue 1, 2010, Pages 27-39

  Panasenko, O M ^a   Sergienko, V I ^a  

^a FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY   (Russian Federation)

Author keywords

Halogenizing stress; Hypobromite; Hypochlorite; Inflammation; Myeloperoxidase; Oesinophilic peroxidase; Reactive forms of halogens

Indexed keywords

EID: 77950144384     PISSN: 08696047     EISSN: 24143545     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Klebanoff S. J. Myeloperoxidase: friend and foe. J. Leukoc. Biol. 2005: 77: 598-625.
2. Schultz J., Kaminker K. Myeloperoxidase of the leucocyte of normal human blood. I. Content and localization. Arch. Biochem. Biophys. 1962; 96: 465-467.
3. Deby-Dupont G., Deby C., Lamy M. Neutrophil myeloperoxidase revisited: its role in health and disease. Intensivmed. 1999; 36: 500-513.
4. Giembycz M. A., Lindsay M. A. Pharmacology of the eosinophil. Pharmacol. Rev. 1999; 51: 213-340.
5. Furtmüller P. G., Burner U., Obinger C. Reaction of myeloperoxidase compound I with chloride, bromide, iodide, and thiocyanate. Biochemistry 1998; 37: 17923-17930.
6. Fiedler T. J., Davey C. A., Fenna R. E. X-ray crystal structure and characterization of halide-binding sites of human myeloperoxidase at 1.8 A resolution. J. Biol. Chem. 2000; 275: 11964-11971.
7. Kettle A. J., Winterboum C. C. Myeloperoxidase: a key regulator of neutrophil oxidant production. Redox Report 1997; 3: 3-15.
8. Kussendrager K D., van Hooijdonk A. C. Lactoperoxidase: physico-chemical properties, occurrence, mechanism of action and applications. Br. J. Nutr. 2000; 84 (suppl. 1): S19-S25.
9. Ruf J., Carayon P. Structural and functional aspects of peroxidase. Arch. Biochem. Biophys. 2006; 445: 269-277.
10. Pattison D. I., Davies M. J. Reactions of myeloperoxidase-derived oxidants with biological substrates: gaining chemical insight into human inflammatory diseases. Cur. Med. Chem. 2006; 13: 3271-3290.
11. Malle E., Marsche G., Arnhold J., Davies M. J. Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid. Biochim. Biophys. Acta 2006; 1761: 392-415.
12. Selye H. The stress of life. New York: McGraw-Hill Book Company Inc.; 1957.
13. Spalteholz H., Panasenko O. M., Arnhold J. Formation of reactive halide species by myeloperoxidase and eosinophil peroxidase. Arch. Biochem. Biophys. 2006; 445: 225-234.
14. Hazen S. L., Hsu F. F.., Duffin K., Heinecke J. W. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxidechloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols. J. Biol. Chem. 1996; 271: 23080-23088.
15. Panasenko O. M., Briviba K., Klotz L.-O., Sies H. Oxidative modification and nitration of human low-density lipoproteins by the reaction of hypochlorous acid with nitrite. Arch. Biochem. Biophys. 1997; 232: 254-259.
16. Thomas E. L., Bozeman P. M., Jefferson M. M., King C. C. Oxidation of bromide by the human leukocyte enzymes myeloperoxidase and eosinophile peroxidase. Formation of bromamines. J. Biol. Chem. 1995; 270: 2906-2913.
17. Senthilmohan R., Kettle A. J. Bromination and chlorination reactions of myeloperoxidase at physiological concentrations of bromide and chloride. Arch. Biochem. Biophys. 2006; 445: 235-244.
18. Kumar K., Day R. A., Margerum D. W. Atom-transfer redox kinetics: general-acid-assisted oxidation of iodide by chloramines and hypochlorite. Inorg. Chem. 1986; 25: 4344-4350.
19. Furtmüller P. G., Burner U., Regelsberger G., Obinger C. Spectral and kinetic studies on the formation of eosinophil peroxidase compound I and its reaction with halides and thiocyanate. Biochemistry 2000; 39: 15578-15584.
20. Hazen S. L., Hsu F. F., Mueller D. M. et al. Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J. Clin. Invest. 1996; 98: 1283-1289.
21. Eiserich J. P., Cross C. E., Jones A. D. et al. Formation of nitrating and chlorinating species by reaction of nutrite with hypochlorous acid. A novel mechanism for nitric oxide-mediated protein modification. J. Biol. Chem. 1996; 271: 19199-19208.
22. Hawkins C. L., Davies M. J. The role of reactive N-bromo species and radical intermediates in hypobromous acid-induced protein oxidation. Free Radie. Biol. Med. 2005; 39: 900-912.
23. Pattison D. I., Davies M. J. Absolute rate constants for the reaction of hypochlorous acid with protein side chains and peptide bonds. Chem. Res. Toxicol. 2001; 14: 1453-1464.
24. Hawkins C. L., Pattison D. I., Daves M. J. Hypochlorite-induced oxidation of amino acids, peptides and proteins. Amino Acids 2003; 25: 259-274.
25. Pattison D. I., Davies M. J. Kinetic analysis of the reactions of hypobromous acid with protein components: implications for cellular damage and use of 3-bromotyrosine as a marker of oxidative stress. Biochemistry 2004; 43: 4799-4809.
26. Panasenko O. M., Arnhold J., Vladimirov Yu. A. et al. Hypochlorite-induced peroxidation of egg yolk phosphatidylcholine is mediated by hydroperoxides. Free Radie. Res. 1997; 27: 1-12.
27. Panasenko O. M., Spalteholz H., Schiller J., Arnhold J. Myeloperoxidase-induced formation of chlorohydrins and lysophospholipids from unsaturated phosphatidylcholines. Free Radic. Biol. Med. 2003; 34: 553-562.
28. Vissers M. C., CarrA. C., Chapman A. L. Comparison of human red cell lysis by hypochlorous and hypobromous acids: insights into the mechanism of lysis. Biochem. J. 1998; 330: 131-138.
29. Panasenko O. M., Vakhrusheva T., Tretyakov Vet al. Influence of chloride on modification of unsaturated phosphatidylcholines by the myeloperoxidase/ hydrogen peroxide/bromide system. Chem. Phys. Lipids 2007; 149: 40-51.
30. Arnhold J., Panasenko O. M., Schiller J. et al. The action of hypochlorous acid on phosphatidylcholine liposomes in dependence on the content of double bonds. Stoichiometry and NMR analysis. Chem. Phys. Lipids 1995; 78: 55-64.
31. Arnhold J., Osipov A. N., Spalteholz H. et al. Formation of lysophospholipids from unsaturated phosphatidylcholines under the influence of hypochlorous acid. Biochim. Biophys. Acta 2002; 1572: 91-100.
32. Arnhold J., Osipov A. N., Spalteholz H. et al. Effects of hypochlorous acid on unsaturated phosphatidylcholines. Free Radie. Biol. Med. 2001; 31: 1111-1119.
33. Kawai Y., Kiyokawa H., Kimura Y. et al. Hypochlorous acid-derived modification of phospholipids: characterization of aminophospholipids as regulatory molecules for lipid peroxidation. Biochemistry 2006; 45: 14201-14211.
34. Panasenko O. M., Arnhold J., Schiller J. et al. Peroxidation of egg yolk phosphatidylcholine liposomes by hypochlorous acid. Biochim. Biophys. Acta 1994; 1215: 259-266.
35. -". Free Radie. Biol. Med. 1994; 16: 143-148.
36. Panasenko O. M., Evgina S. A., Driomina E. S. et al. Hypochlorite induces lipid peroxidation in blood lipoproteins and phospholipid liposomes. Free Radic. Biol. Med. 1995; 19: 133-140.
37. Panasenko O. M. The mechanism of the hypochlorite-induced lipid peroxidation. BioFactors 1997; 6: 181-190.
38. Panasenko O. M., Arnhold J. Linoleic acid hydroperoxide favours hypochlorite- and myeloperoxidase-induced lipid peroxidation. Free Radie. Res. 1999; 30: 479-487.
39. Osipov A. N., Panasenko O. M., Chekanov A. V., Arnhold J. Interaction of tert-butyl hydroperoxide with hypochlorous acid. A spin trappirg and chemiluminescence study. Free Radic. Res. 2002; 36: 749-754.
40. Rees M. D., Hawkins C. L., Davies M. J. Hypochlorite-mediated fragmentation of hyaluronan, chondroitin sulfates, and related N-acetyl glycosamines: evidence for chloramide intermediates, free radical transfer reactions, and site-specific fragmentation. J. Am. Chem. Soc. 2003; 125: 13719-13733.
41. Rees M. D., Mcniven T. N., Davies M. J. Degradation of extracellular matrix and its components by hypobromous acid. Biochem. J. 2007; 401: 587-596.
42. Prutz W. A. Hypochlorous acid interactions with thiols, nucleotides, DNA, and other biological substrates. Arch. Biochem. Biophys. 1996; 332: 110-120.
43. Hawkins C. L., Davies M. J. Hypochlorite-induced damage to nucleosides: formation of chloramines and nitrogen-centered radicals. Chem. Res. Toxicol. 2001; 14: 1071-1081.
44. Hawkins C. L., Davies M. J. Hypochlorite-induced damage to DNA, RNA, and polynucleotides: formation of chloramines and nitrogen-centered radicals. Chem. Res. Toxicol. 2002; 15: 83-92.
45. Sies H. Oxidative stress: oxidants and antioxidants. Exp. Physiol. 1997; 82 (2): 291-295.
46. Halliwell B. Hypothesis: proteasomal dysfunction: a primary event in neurogeneration that leads to nitrative and oxidative stress and subsequent cell death. Ann. N. Y. Acad. Sci. 2002; 962: 182-194.
47. Kanofsky J. R. Singlet oxygen production by chloroperoxidasehydrogen peroxide-halide systems. J. Biol. Chem. 1984; 259: 5596-5600.
48. Bajaj M. S., Kew R. R., Webster R. O., Hyers T. M. Priming of human neutrophil functions by tumor necrosis factor: enhancement of superoxide anion generation, degranulation, and Chemotaxis to chemoattractants C5a and F-Met-Leu-Phe. Inflammation 1992; 16: 241-250.
49. Liu L., Wang Y. X., Zhou J. et al. Rapid non-genomic inhibitory effects of glucocorticoids on human neutrophil degranulation. Inflamm. Res. 2005; 54: 37-41.
50. Burt H. M., Jackson J. K, Dryden P., Salari H. Crystal-induced protein tyrosine phosphorylation in neutrophils and the effect of a tyrosine kinase inhibitor on neutrophil responses. Mol. Pharmacol. 1993; 43: 30-36.
51. Gatt M. E., Urieli-Shoval S., Preciado-Patt L. et al. Effect of serum amyloid A on selected in vitro functions of isolated human neutrophils. J. Lab. Clin. Med. 1998; 132: 414-420.
52. Sokolov A. V., Ageeva K V., Pulina M. O. et al. Ceruloplasmin and myeloperoxidase in complex affect the enzymatic properties of each other. Free Radic. Res. 2008; 42: 989-998.
53. Jantschko W., Furtmüller P. G., Allegro M. et al. Redox intermediates of plant and mammalian peroxidase: a comparative transient-kinetic of their reactivity toward indole derivatives. Arch. Biochem. Biophys. 2002; 398: 12-22.
54. Galijasevic S., Abdulhamid I., Abu-Soud H. M. Potential role of tryptophan and chloride in the inhibition of human myeloperoxidase. Free Radic. Biol. Med. 2008; 44: 1570-1577.
55. -. Biochem. Int. 1988; 17: 783-790.
56. Hazen S. L., Heinecke J. W. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. 1997; 99: 2075-2081.
57. Saude E. J., Lacy P., Musat-Marcu S. et al. NMR analysis of neutrophil activation in sputum samples from patients with cystic fibrosis. Magn. Reson. Med. 2004; 52: 807-814.
58. Higashi N., Mita H., Taniguchl M. et al. Urinary eicosanoid and tyrosine derivative concentrations in patients with vasculitides. J. Allergy Clin. Immunol. 2004; 114: 1353-1358.
59. Himmelfarb J., McMenamin M. E., Loseto G., Heinecke J. W. Myeloperoxidase-catalyzed 3-chlorotyrosine formation in dialysis patients. Free Radic. Biol. Med. 2001; 31: 1163-1169.
60. Mita H., Higashi N., Taniguchi M. et al. Urinary 3-bromotyrosine and 3-chlorotysine concentrations in asthmatic patients: lack of increase in 3-bromotyrosine concentration in urine and plasma proteins in aspirin-induced asthma after intravenous aspirin challenge. Clin. Exp. Allergy, 2004; 34: 931-938.
61. Lamb N. J., Gutteridge J. M., Baker C. et al. Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: evidence for neutrophil-mediated hydroxylation, nitration, and chlorination. Crit. Care Med. 1999; 27: 1738-1744.
62. Buss I. H., Senthilmohan R., Darlow B. A. et al. 3-Chlorotyrosine as a marker of protein damage by myeloperoxidase in tracheal aspirates from preterm infants: association with adverse respiratory outcome. Pediatr. Res. 2003; 53: 455-462.
63. Hazell L. J., Arnold L., Flowers D. et al. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J. Clin. Invest. 1996; 97: 1535-1544.
64. Malle E., Woenckhaus C., Waeg G. et al. Immunological evidence for hypochloritemodified proteins in human kidney. Am. J. Pathol. 1997; 150: 603-615.
65. Messner M. C., Albert C. J., McHowat J., Ford D. A. Identification of lysophosphatidylcholine-chlorohydrin in human atherosclerotic lesions. Lipids 2008; 43: 243-249.
66. Thukkanl A. K., McHowat J., Hsu F. F. et al. Identification of alpha-chloro fatty aldehydes and unsaturated lyphosphatidylcholine molecular species in human atherosclerotic lesions. Circulation 2003; 108: 3128-3133.
67. Takeshlta J., Byun J., Nhan T. Q. et al. Myeloperoxidase generates 5-chlorouracil in human atherosclerotic tissue. J. Biol. Chem. 2006; 281: 3096-3104.